Clinical Trials
43 trialsA Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
ICEMELT
Western Sydney Local Health District
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
Chongqing Precision Biotech Co., Ltd
REGOMUNE
Institut Bergonié
RiME
University of Kansas Medical Center
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes
Henan Cancer Hospital
PA001
Hospital Universitario San Ignacio
Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors
Chongqing Precision Biotech Co., Ltd
Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital of Zhengzhou University
A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies
Eutilex
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
Tsinghua University
PEN-866 in Patients With Advanced Solid Malignancies
Tarveda Therapeutics
Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC
Qilu Hospital of Shandong University
Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer
Seoul National University Bundang Hospital
IPXELOX
Seoul St. Mary's Hospital
Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)
Yonsei University
Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer
Yonsei University
Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer
Ruijin Hospital
Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies
Shenzhen BinDeBio Ltd.
Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment
The Second Hospital of Shandong University
4SCAR-CD44v6 T Cell Therapy Targeting Cancer
Shenzhen Geno-Immune Medical Institute
Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)
Ruijin Hospital
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
Safety and Efficacy of γδ T Cell Against Gastric Cancer
Beijing Doing Biomedical Co., Ltd.
AZD8186 and Paclitaxel in Advanced Gastric Cancer
Seoul National University Bundang Hospital
XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
Anhui Provincial Hospital
Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer
ChineseAMS
PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
CARTEPC
First Affiliated Hospital of Chengdu Medical College
CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer
National University Hospital, Singapore
NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer
National University Hospital, Singapore
Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer
Xuzhou Medical University
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer
ChineseAMS
Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96
Chinese PLA General Hospital
Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis
Second Military Medical University
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors
Hanmi Pharmaceutical Company Limited
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Rutgers, The State University of New Jersey
Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer
Genta Incorporated
A Study of Oraxol® in Gastric Cancer Patients
Hanmi Pharmaceutical Company Limited
Efficacy Study of TKcell in Advanced Gastric Cancer
Binex